Welcome Guest | Register / Login

Biotechnology Market Research Reports

Sort By
Title Published Price Buy Now
Factor IX - Pipeline Insight, 2019
By Delve Insight
"Factor IX - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Factor IX development. The report provides detailed coverage of the pipel...
Jan 2019 $ 1250
Factor IX A Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Factor IX A Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Factor IX A Inhibitor development. The report provides detail...
Jan 2019 $ 1250
Factor VIIa Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Factor VIIa Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Factor VIIa Inhibitor development. The report provides detail...
Jan 2019 $ 1250
Factor VIII Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Factor VIII Inhibitor - Pipeline Insights, 2019" report by DelveInsight outlays comprehensive insights of present scenario and growth prospects across Factor VIII Inhibitor. A detailed picture of the pipeline landscape is provided with summation of ...
Jan 2019 $ 1250
Farnesoid X Receptor (FXR) Agonist - Pipeline Insight, 2019
By Delve Insight
"Farnesoid X Receptor (FXR) Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Farnesoid X Receptor (FXR) Agonist development. ...
Jan 2019 $ 1250
Fatty Acid Amide Hydrolase (FAAH) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Fatty Acid Amide Hydrolase (FAAH) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Fatty Acid Amide Hydrolase (FAAH) Inhib...
Jan 2019 $ 1250
Fatty Acid Synthase (FAS) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Fatty Acid Synthase (FAS) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Fatty Acid Synthase (FAS) Inhibitor development...
Jan 2019 $ 1250
Fc-Gamma Receptor Antagonist - Pipeline Insight, 2019
By Delve Insight
"Fc-Gamma Receptor Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Fc-Gamma Receptor Antagonist development. The report p...
Jan 2019 $ 1250
Fibroblast Activation Protein (FAP or Seprase) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Fibroblast Activation Protein (FAP or Seprase) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Fibroblast Activation Prot...
Jan 2019 $ 1250
Fibroblast Growth Factor (FGF) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Fibroblast Growth Factor (FGF) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Fibroblast Growth Factor (FGF) Inhibitor d...
Jan 2019 $ 1250
Fibroblast Growth Factor 1 (FGF-1) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Fibroblast Growth Factor 1 (FGF-1) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Fibroblast Growth Factor 1 (FGF-1) Inh...
Jan 2019 $ 1250
Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Fibroblast Growth Factor Rece...
Jan 2019 $ 1250
Focal Adhesion Kinase (FAK) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Focal Adhesion Kinase (FAK) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Focal Adhesion Kinase (FAK) Inhibitor develop...
Jan 2019 $ 1250
GABA Transaminase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"GABA Transaminase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "GABA Transaminase Inhibitor development. The report pro...
Jan 2019 $ 1250
GABAA Modulators - Pipeline Insight, 2019
By Delve Insight
"GABAA Modulators - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "GABAA Modulators development. The report provides detailed coverag...
Jan 2019 $ 1250
GABAB Agonist - Pipeline Insight, 2019
By Delve Insight
"GABAB Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "GABAB Agonist development. The report provides detailed coverage of t...
Jan 2019 $ 1250
Galectin Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Galectin Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Galectin Inhibitor development. The report provides detailed cov...
Jan 2019 $ 1250
Gamma Secretase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Gamma Secretase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Gamma Secretase Inhibitor development. The report provide...
Jan 2019 $ 1250
Ghrelin Receptor Agonist - Pipeline Insight, 2019
By Delve Insight
"Ghrelin Receptor Agonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Ghrelin Receptor Agonist development. The report provides ...
Jan 2019 $ 1250
Glucagon Receptor Antagonist - Pipeline Insight, 2019
By Delve Insight
"Glucagon Receptor Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Glucagon Receptor Antagonist development. The report p...
Jan 2019 $ 1250
Glucocorticoid Receptor (GR) Antagonist - Pipeline Insight, 2019
By Delve Insight
"Glucocorticoid Receptor (GR) Antagonist - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Glucocorticoid Receptor (GR) Antagonist dev...
Jan 2019 $ 1250
Glucosylceramide Synthase Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Glucosylceramide Synthase Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Glucosylceramide Synthase Inhibitor development...
Jan 2019 $ 1250
Glycan Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Glycan Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Glycan Inhibitor development. The report provides detailed coverag...
Jan 2019 $ 1250
Glycine Transporter Type-1 (Glyt-1) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Glycine Transporter Type-1 (Glyt-1) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Glycine Transporter Type-1 (Glyt-1) I...
Jan 2019 $ 1250
Glycogen Synthase Kinase 3 (GSK-3) Inhibitor - Pipeline Insight, 2019
By Delve Insight
"Glycogen Synthase Kinase 3 (GSK-3) Inhibitor - Pipeline Insight, 2019" report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across "Glycogen Synthase Kinase 3 (GSK-3) Inh...
Jan 2019 $ 1250
We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy